NSE ScannerOpen the scanner

Trading & Distribution · Wholesale Distributors · NSE: SAROJA · data 2026-10-30

Saroja Pharma Industries India Ltd.

₹38.8-4.90% on 28 OctHealth: Strong 7.2/10

In plain words

Price: 10.4% below its 52-week high of ₹43.3.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹38.8
Market cap
₹16 cr
P/E
9.7
P/B
0.9
ROE
9.8%
ROCE
17.9%
Debt / equity
0.83
Dividend yield
0.00%
1-year return
-11.1%
52-week high
₹43.3
52-week low
₹28
Operating margin
5.7%

Growth

Revenue (last 12 months)₹71 cr
Net profit (last 12 months)₹2 cr
Sales growth, 3 years (yearly)11.8%
Profit growth, 3 years (yearly)15.0%

Smart-money activity

5/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Saroja Pharma Industries India Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.83.

What is Saroja Pharma Industries India Ltd.'s P/E ratio?

About 9.7, based on the last 12 months' earnings and a price of ₹38.8 (data 2026-10-30).

What is the 52-week high and low of Saroja Pharma Industries India Ltd.?

The 52-week high is ₹43.3 and the 52-week low is ₹28.

Similar companies

QVC Exports Limited (QVCEL) · Aspire & Innovative Advertising Limited (ASPIRE) · Sri Havisha Hospitality And Infrastructure Ltd (HAVISHA) · Agarwal Float Glass India Limited (AGARWALFT) · Shrenik Limited (SHRENIK)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SAROJA in NSE Scanner →
Share on WhatsAppShare on Telegram